Skip to content

Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden

Characteristics and Outcomes of Critically Ill Patients With Covid-19 in a Large Swedish County Hospital - a Prospective Observational Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04382417
Enrollment
57
Registered
2020-05-11
Start date
2020-03-26
Completion date
2020-11-12
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19, Critical Illness

Brief summary

The study will prospectively collect data from patients with Covid-19 admitted to the Västerås Intensive Care Unit, Västerås Hospital. Demographic, clinical, radiographic and laboratory characteristics will be recorded. Analysis of data to identify predictors of disease severity, mortality and treatment response.

Interventions

OTHERObservational study

Not required

Sponsors

Region Västmanland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients admitted to the Intensive Care Unit with biological samples positive for SARS-CoV-2. * Patients admitted to the Intensive Care Unit with one or more negative tests but with clinical and radiological characteristics highly suggestive of SARS-CoV-2 and thus considered positive for the disease.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frame
All-cause mortalityAt 90 days follow-up after admittance to Intensive Care

Secondary

MeasureTime frame
ICU length of stayUntil 90 days after admittance to Intensive Care
Number of days on mechanical ventilationUntil 90 days after admittance to Intensive Care
Hospital length of stayUntil 90 days after admittance to Intensive Care
Number of patients receiving renal replacement therapyUntil 90 days after admittance to Intensive Care
Patient characteristicsAt admission to ICU
Number of patients receiving vasopressor supportUntil 90 days after admittance to Intensive Care

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026